CONMED Corporation announced the appointment of Kim Kelderman to its Board of Directors, effective September 8, 2025. Mr. Kelderman currently serves as President, Chief Executive Officer, and a board member of Bio-Techne.
Mr. Kelderman brings extensive global leadership experience across life sciences businesses, with a strong track record in innovation and strategy. His previous roles include leadership positions at Thermo Fisher Scientific and Becton Dickinson.
The addition of Mr. Kelderman's skills and insights is expected to be a valuable asset to the board. His expertise will support CONMED in pursuing its long-term vision and delivering value across its stakeholder community.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.